Literature DB >> 19847629

Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.

Martin J Wolfsegger1, Thomas Jaki.   

Abstract

Pharmacokinetic studies are commonly analyzed using a two-stage approach where the first stage involves estimation of pharmacokinetic parameters for each subject separately and the second stage uses the individual parameter estimates for statistical inference. This two-stage approach is not applicable in sparse sampling situations where only one sample is available per subject. Nonlinear models are often applied to analyze pharmacokinetic data assessed in such serial sampling designs. Modelling approaches are suitable provided that the form of the true model is known, which is rarely the case in early stages of drug development. This paper presents an alternative approach to estimate pharmacokinetic parameters based on non-compartmental and asymptotic theories in the case of serial sampling when a drug is given as an intravenous bolus. The statistical properties of estimators of the pharmacokinetic parameters are investigated and evaluated using Monte Carlo simulations.

Mesh:

Substances:

Year:  2009        PMID: 19847629     DOI: 10.1007/s10928-009-9133-9

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  13 in total

Review 1.  Multiple imputation: a primer.

Authors:  J L Schafer
Journal:  Stat Methods Med Res       Date:  1999-03       Impact factor: 3.021

2.  Statistical issues in a modeling approach to assessing bioequivalence or PK similarity with presence of sparsely sampled subjects.

Authors:  Chuanpu Hu; Katy H P Moore; Yong H Kim; Mark E Sale
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-08       Impact factor: 2.745

3.  Estimation of AUC from 0 to Infinity in Serial Sacrifice Designs.

Authors:  Martin Josef Wolfsegger; Thomas Jaki
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12       Impact factor: 2.745

4.  Establishing bioequivalence in serial sacrifice designs.

Authors:  Martin J Wolfsegger
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-12       Impact factor: 2.745

5.  Confidence intervals for ratios of AUCs in the case of serial sampling: a comparison of seven methods.

Authors:  Thomas Jaki; Martin J Wolfsegger; Meinhard Ploner
Journal:  Pharm Stat       Date:  2009 Jan-Mar       Impact factor: 1.894

6.  Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data.

Authors:  R C Gagnon; J J Peterson
Journal:  J Pharmacokinet Biopharm       Date:  1998-02

7.  A note on testing areas under the curve when using destructive measurement techniques.

Authors:  H Heinzl
Journal:  J Pharmacokinet Biopharm       Date:  1996-12

8.  Optimal design allocations for estimating area under curves for studies employing destructive sampling.

Authors:  W W Piegorsch; A J Bailer
Journal:  J Pharmacokinet Biopharm       Date:  1989-08

9.  Testing for the equality of area under the curves when using destructive measurement techniques.

Authors:  A J Bailer
Journal:  J Pharmacokinet Biopharm       Date:  1988-06

10.  Applying Bailer's method for AUC confidence intervals to sparse sampling.

Authors:  J R Nedelman; E Gibiansky; D T Lau
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

View more
  3 in total

1.  Trends in biomedical informatics: most cited topics from recent years.

Authors:  Hyeon-Eui Kim; Xiaoqian Jiang; Jihoon Kim; Lucila Ohno-Machado
Journal:  J Am Med Inform Assoc       Date:  2011-12       Impact factor: 4.497

2.  Bayesian approach to estimate AUC, partition coefficient and drug targeting index for studies with serial sacrifice design.

Authors:  Tianli Wang; Kyle Baron; Wei Zhong; Richard Brundage; William Elmquist
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

3.  Preferential Delivery of an Opioid Antagonist to the Fetal Brain in Pregnant Mice.

Authors:  John Oberdick; Yonghua Ling; Mitch A Phelps; Max S Yudovich; Karl Schilling; Wolfgang Sadee
Journal:  J Pharmacol Exp Ther       Date:  2016-05-05       Impact factor: 4.030

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.